Yes, This Is Parody. We Looked It Up. This website constitutes a work of parody, satire, and opinion commentary protected under the First Amendment of the United States Constitution, the common law doctrine of fair comment, and applicable state and federal free speech protections. It is not affiliated with, sponsored by, endorsed by, or connected in any way to Josh Bersin, The Josh Bersin Company, Galileo, or any related entity or affiliate thereof.

These Are Personal Opinions. Nobody Paid For Them. All statements, analysis, characterizations, editorial commentary, and viewpoints expressed on this site are personal opinions published for informational and commentary purposes. They do not represent the views, positions, policies, or opinions of any employer, client, partner, board, or affiliated organization, past or present.

The Numbers Are Probably Low, Not High. The publication counts, Galileo mention figures, percentage rates, and all statistical data presented on this site are partial, non-exhaustive estimates derived solely from publicly accessible and freely indexed web content, including but not limited to joshbersin.com, joshbersin.substack.com, and publicly indexed LinkedIn content. This site does not and cannot access paywalled content, corporate membership content, private newsletters, unlisted podcast episodes, gated research reports, or any other non-public material. Accordingly, actual publication volumes and Galileo mention frequencies are likely higher than reported here for two independent reasons: (1) not all platforms are crawled, and (2) the counting methodology is intentionally conservative, excluding navigational and structural page elements that reference Galileo outside the editorial body of any article. These figures should be understood as a deliberately conservative floor estimate only, not a complete or definitive count. They are not audited, certified, verified by any third party, or guaranteed to be accurate, current, or complete.

How We Count (And Why We Count Less Than We Could). This site is intentionally designed to err on the side of undercounting. Galileo mention counts are generated by automated text-matching applied exclusively to article body paragraph text. To avoid inflating counts with non-editorial references, the crawler actively excludes mentions appearing in navigation menus, site headers, site footers, sidebars, hyperlink anchor text, promotional banners, subscription call-to-action elements, and other structural page components that are not part of the authored editorial content of any given publication. As a direct consequence of these conservative exclusions, the Galileo mention counts presented on this site are in all likelihood lower than the actual number of times the word appears across the subject's published output. The figures should therefore be understood as a deliberately conservative floor estimate. Any person seeking to challenge these counts on the basis that they are inflated is directed to review the methodology above. No human editorial review of every individual match has been performed. The "days since last mention" figure is an approximation based on the most recent crawled publication date and should not be treated as precise.

This Is Not Defamation. Here Is Why. Nothing on this site is intended to constitute defamation, libel, slander, trade libel, or malicious falsehood under any applicable law. All commentary is based exclusively on publicly available information and represents the author's good-faith opinion on matters of legitimate public concern in the HR technology industry. Josh Bersin is a public figure who has voluntarily entered public discourse regarding HR technology markets, AI products, and analyst independence. Commentary on the conduct of public figures in their public professional capacity is protected expression.

We Quoted Some Things. That Is Allowed. Any quotations, excerpts, or references to third-party publications appearing on this site are reproduced for the sole purposes of commentary, criticism, and parody, and are believed to constitute fair use under 17 U.S.C. § 107. No endorsement by, affiliation with, or sponsorship by any quoted party is expressed or implied. Direct links to source material are provided wherever possible to enable independent verification.

This Is Not Investment Advice. Please. Nothing on this site constitutes legal, financial, investment, securities, or professional advice of any kind. This site is published solely for informational, satirical, and commentary purposes. Do not rely on any data or statement herein for any commercial, legal, regulatory, investment, or business decision.

A Robot Read His Website. Publicly. That Is Legal. This site uses automated web crawling to periodically retrieve publicly accessible HTML content from publicly indexed URLs. No authentication credentials are used. No paywalled, subscription-gated, or otherwise access-restricted content is accessed, reproduced, or stored. All URLs crawled are publicly listed in XML sitemaps or RSS feeds. Data is refreshed on an automated weekly schedule and may not reflect publications made in the intervening period.

We Probably Missed Some. The Real Number Is Higher. This site does not claim to represent, track, or account for the totality of Josh Bersin's published output across all platforms, formats, or channels. Significant publication activity may occur on platforms not crawled by this site, including but not limited to LinkedIn, Forbes, Harvard Business Review, conference presentations, keynote transcripts, webinar recordings, press releases, and third-party syndicated content. The absence of a publication from this tracker does not imply that publication does not exist or did not mention Galileo.

Maybe the FTC Should Pay Attention. Just a Thought. We are not lawyers. We are not regulators. We are not accusing anyone of anything. But we did read 16 CFR Part 255 — the FTC Endorsement Guides — because apparently we have that kind of free time now.

Here is what those guides say, in plain English: if you have a financial relationship with a company whose products you write about, you must disclose that relationship clearly and conspicuously at the point of recommendation. Not buried in a bio. Not on an about page three clicks deep. Right there, before the reader forms an opinion.

A "material connection" under the guides includes paid partnerships, commercial sponsorship arrangements, and any financial relationship that might affect how much weight a reasonable reader gives to a recommendation. The FTC expanded enforcement beyond bloggers and influencers in recent years — the guides now explicitly cover "any connection between an endorser and the seller of an advertised product or service" that could materially affect credibility.

Now consider two things happening simultaneously in this particular case, as a purely hypothetical intellectual exercise:

(1) An "Innovation Partner" program — a paid commercial arrangement with vendors who are then written about and evaluated in research positioned as independent analysis.
(2) A proprietary AI product being recommended inside that same research — sometimes multiple times per article — creating a situation where the analyst is simultaneously evaluating a market and selling into it.

Neither alone is necessarily a problem. Both together, without clear disclosure at the point of each individual recommendation? That is where it gets interesting from a regulatory perspective.

The FTC guides apply to endorsements, not pure independent analysis. Whether any particular content qualifies as an endorsement versus independent research is exactly the kind of line that lawyers get paid a lot of money to argue about. But we will note — with no legal opinion expressed or implied — that a dataset of ~742 product appearances across ~153 articles over 28 months might make the "this is just independent research" argument slightly more aerodynamic than structurally sound.

We are not saying anyone is violating FTC guidelines. We are not saying anyone isn't. We are saying we have feelings about it. Feelings are not facts. But maybe the fact-finders — the ones with subpoena power and .gov email addresses — should take a look and make that determination themselves. We'll be here. Counting.

This section constitutes protected opinion commentary on matters of legitimate public interest regarding disclosure practices in the analyst industry. It is not legal advice, not a formal complaint, and not an accusation of wrongdoing. If it were any of those things, it would be a lot less fun to read.

Think We Got Something Wrong? Prove It. If you believe any factual data point on this site is materially and demonstrably inaccurate based on verifiable public evidence, corrections may be submitted via the contact information listed on this domain. Good-faith, evidence-supported correction requests will be reviewed and addressed promptly. The publisher reserves the right to exercise editorial judgment in determining what constitutes a material inaccuracy versus a difference of estimation methodology.

Maybe the FTC Should Pay Attention. Just a Thought. We are not lawyers. We are not regulators. We are not accusing anyone of anything. But we did read 16 CFR Part 255 — the FTC Endorsement Guides — because apparently we have that kind of free time now.

Here is what those guides say, in plain English: if you have a financial relationship with a company whose products you write about, you must disclose that relationship clearly and conspicuously at the point of recommendation. Not buried in a bio. Not on an about page three clicks deep. Right there, before the reader forms an opinion.

A "material connection" under the guides includes paid partnerships, commercial sponsorship arrangements, and any financial relationship that might affect how much weight a reasonable reader gives to a recommendation. The FTC expanded enforcement beyond bloggers and influencers in recent years — the guides now explicitly cover "any connection between an endorser and the seller of an advertised product or service" that could materially affect credibility.

Now consider two things happening simultaneously in this particular case, as a purely hypothetical intellectual exercise:

(1) An "Innovation Partner" program — a paid commercial arrangement with vendors who are then written about and evaluated in research positioned as independent analysis.
(2) A proprietary AI product being recommended inside that same research — sometimes multiple times per article — creating a situation where the analyst is simultaneously evaluating a market and selling into it.

Neither alone is necessarily a problem. Both together, without clear disclosure at the point of each individual recommendation? That is where it gets interesting from a regulatory perspective.

The FTC guides apply to endorsements, not pure independent analysis. Whether any particular content qualifies as an endorsement versus independent research is exactly the kind of line that lawyers get paid a lot of money to argue about. But we will note — with no legal opinion expressed or implied — that a dataset of ~742 product appearances across ~153 articles over 28 months might make the "this is just independent research" argument slightly more aerodynamic than structurally sound.

We are not saying anyone is violating FTC guidelines. We are not saying anyone isn't. We are saying we have feelings about it. Feelings are not facts. But maybe the fact-finders — the ones with subpoena power and .gov email addresses — should take a look and make that determination themselves. We'll be here. Counting.

This section constitutes protected opinion commentary on matters of legitimate public interest regarding disclosure practices in the analyst industry. It is not legal advice, not a formal complaint, and not an accusation of wrongdoing. If it were any of those things, it would be a lot less fun to read.